ShadowBuys
Committee overlap: Energy and Commerce

Rep. Thomas H. Kean, Jr. sold Abbott Laboratories (ABT)

Rep. Thomas H. Kean, Jr. (R-NJ-7) · $1K–$15K · traded Sep 17, 2026

Why this is a committee overlap

Kean is a member of the House Committee on Energy and Commerce, which oversees the Healthcare sector. Abbott Laboratories is classified in the Medical - Devices industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Not stated
Traded
Sep 17, 2026
Disclosed
Oct 30, 2026
Days to disclose
43
Asset type
Stock
As filed
Abbott Laboratories Common Stock
Industry
Medical - Devices · Healthcare

Other trades in this filing

Recent Congress trades in ABT

Company context for ABT

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ABTContract award·USAspending

    ABT: Department of Health and Human Services contract award

    GIMC NUTRITION SERVICES - ABBOTT NUTRITION RETAIL - NUTRITIONAL SUPPLEMENT FOOD PRODUCTS AND SUPPLIES BPA

    First observed: Nov 8, 2026, 12:28 PM ESTEvent / period: Sep 19, 2023Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    PH REF LAB INSTRUMENT MAINT

    First observed: Nov 8, 2026, 11:39 AM ESTEvent / period: Sep 9, 2022Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    PROPRIETARY LABORATORY INSTRUMENT SUPPORT & MAINTENANCE

    First observed: Nov 8, 2026, 11:39 AM ESTEvent / period: Sep 16, 2022Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.